Lv11
50 积分 2025-03-18 加入
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
3小时前
已完结
The status of tumor mutational burden and immunotherapy
10小时前
已完结
Epstein-Barr Virus Infection
7天前
已完结
Epstein-Barr virus infection
7天前
已关闭
Incidence, mortality and survival of childhood cancer in China during 2000–2010 period: A population-based study
8天前
已完结
Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study
8天前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
11天前
已完结
Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial)
22天前
已完结
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
22天前
已完结
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
26天前
已完结
皖公网安备34019202002308
